ClinicaliQ Trial Snapshot
- Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019 — Recruiting • Phase I • NCT07479745.
- This study tracks how the body absorbs, breaks down and eliminates a single dose of an experimental drug called GRT6019.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 ([14C]) GRT6019 Conditions: Healthy Male Volunteers Interventions: [14C]GRT6019 Lead Sponsor: Grünenthal GmbH Planned Enrollment: 10 participants